twitter
en POLSKI
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Current issue Archive Videos Articles in press About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2023
vol. 125
 
Share:
Share:
abstract:
Case report

Valsalva retinopathy – a patient with a Leiden mutation in the coagulation factor V gene and increased blood clotting

Aleksander Lamkowski
1
,
Martyna Kałużna
1
,
Tomasz Pabin
1

1.
Department of Ophthalmology, Voivodeship Hospital in Koszalin
KLINIKA OCZNA 2023, 125, 1: 56-59
Online publish date: 2023/02/09
View full text Get citation
 
PlumX metrics:
Valsalva retinopathy is a rare disease in which the pressure in the eye increases, leading to the development of a pre-retinal hemorrhage. It frequently occurs in completely healthy patients and leads to sudden and painless vision loss. It may arise due to vomiting, coughing, constipation, pregnancy, childbirth, and intense physical or sexual activity. In this article, we describe the case of a young man who developed Valsalva retinopathy. The development and progression of nuclear cataracts may be influenced by many factors such as the process of lens oxidation, the use of infusion fluids, light toxicity, duration of vitrectomy or the type of endotamponade. The key to preventing cataract formation after vitrectomy is still elusive.

keywords:

Leiden mutation, Valsalva retinopathy, Nd:Yag laser, preretinal hemorrhage, increased blood clotting

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.